GO
Loading...

Medtronic Inc

More

  • April 15- ConMed Corp, a surgical device maker that has been fighting off activist investors, is exploring a sale and has contacted large medical device companies to gauge their buyout interest, people familiar with the matter said on Tuesday.

  • Final Glance: Medical Devices companies Monday, 14 Apr 2014 | 6:01 PM ET

    Allergan rose $3.08 or 2.5 percent, to $123.97. Baxter International Inc. rose$. 78 or 1.1 percent, to $72.76. Boston Scientific Corp. rose$. 62 or 4.9 percent, to $13.31.

  • *Citigroup is one of S&P's biggest gainers after results. NEW YORK, April 14- U.S. stocks closed higher on Monday as Citigroup's earnings and strong retail sales gave investors reasons to buy equities despite a resurgence of geopolitical uncertainties.

  • WebMd and Citigroup are big market movers Monday, 14 Apr 2014 | 4:32 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:. Edwards Lifesciences Corp., up $8.03 to $81. Citigroup Inc., up $1.99 to $47.67.

  • *Citigroup one of S&P's biggest gainers after results. NEW YORK, April 14- U.S. stocks rose on Monday, rebounding after a sharp selloff in the previous session as strong results from Citigroup and bullish retail sales data lifted sentiment.

  • Midday Glance: Medical Devices companies Monday, 14 Apr 2014 | 2:08 PM ET

    Allergan rose $3.06 or 2.5 percent, to $123.95. Baxter International Inc. rose$. 79 or 1.1 percent, to $72.77. Boston Scientific Corp. rose$. 51 or 4.0 percent, to $13.20.

  • Edwards jumps after injunction against Medtronic Monday, 14 Apr 2014 | 12:52 PM ET

    On Friday the companies said the U.S. District Court for the District of Delaware granted a preliminary injunction that blocks sales of Medtronic's CoreValve in the U.S. The ruling doesn't affect clinical trials of CoreValve in the U.S. or sales in other countries, Medtronic said. Medtronic Inc. stock lost $1.20, or 2 percent, to $58.

  • April 14- Shares of medical device maker Medtronic Inc fell as much as 6 percent after a U.S. court temporarily halted sales of its aortic heart valve replacement system in the country.

  • NEW YORK, April 14- U.S. stocks bounced back on Monday, following a sharp selloff last session, with earnings results from Citigroup and retail sales data lifting sentiment while traders kept tabs on the possible escalation of hostilities in Ukraine.

  • Early Glance: Medical Devices companies Monday, 14 Apr 2014 | 10:21 AM ET

    Allergan rose$. 47 or. 4 percent, to $121.36. Baxter International Inc. rose$. 47 or. 7 percent, to $72.45. Boston Scientific Corp. rose$. 48 or 3.8 percent, to $13.17.

  • US stocks recover some ground on retail sales gain Monday, 14 Apr 2014 | 9:13 AM ET

    But the market pushed higher from the get-go Monday, receiving a boost from solid earnings from Citigroup and a strong pickup in retail sales last month. Among the stocks that rose sharply were WebMD, Edwards Lifesciences and Goodrich Petroleum. Citigroup helped stoke the rally.

  • NEW YORK, April 14- U.S. stocks were set to open higher on Monday, following a sharp selloff last session, with earnings results from Citigroup and retail sales data lifting sentiment while traders kept tabs on the possible escalation of hostilities in Ukraine.

  • *Edwards Lifesciences shares rally after court ruling. *Ukraine's acting president threatens military action. NEW YORK, April 14- U.S. stock index futures edged higher on Monday, following a slarge selloff last session, with earnings results from Citigroup lifting sentiment while traders kept tabs on the possible escalation of hostilities in Ukraine.

  • Final Glance: Medical Devices companies Friday, 11 Apr 2014 | 6:03 PM ET

    Allergan rose $4.26 or 3.7 percent, to $120.89. Baxter International Inc. fell$. 28 or. 4 percent, to $71.98. Boston Scientific Corp. fell$. 24 or 1.9 percent, to $12.69.

  • Midday Glance: Medical Devices companies Friday, 11 Apr 2014 | 1:51 PM ET

    Allergan rose $4.38 or 3.8 percent, to $121.00. Baxter International Inc. rose$. 15 or. 2 percent, to $72.41. Boston Scientific Corp. fell$. 32 or 2.4 percent, to $12.62.

  • Early Glance: Medical Devices companies Thursday, 10 Apr 2014 | 10:24 AM ET

    Allergan fell $1.17 or 1.0 percent, to $119.74. Baxter International Inc. fell$. 37 or. 5 percent, to $73.08. Boston Scientific Corp. fell$. 18 or 1.3 percent, to $13.36.

  • Final Glance: Medical Devices companies Wednesday, 9 Apr 2014 | 6:06 PM ET

    Allergan rose $3.00 or 2.5 percent, to $120.91. Baxter International Inc. rose $1.15 or 1.6 percent, to $73.45. Boston Scientific Corp. rose$. 63 or 4.9 percent, to $13.54.

  • Wall Street analysts had estimated a potential market of $3 billion for the devices made by Medtronic Inc, Boston Scientific Corp and St Jude Medical Inc. But failure of the high-stakes clinical trial set off a heated debate between doctors who believe the approach is worth saving and those who say results show it provides no clear benefit.

  • Midday Glance: Medical Devices companies Wednesday, 9 Apr 2014 | 1:15 PM ET

    Allergan rose $1.95 or 1.7 percent, to $119.86. Baxter International Inc. rose$. 62 or. 9 percent, to $72.92. Boston Scientific Corp. rose$. 47 or 3.6 percent, to $13.38.

  • Early Glance: Medical Devices companies Tuesday, 8 Apr 2014 | 10:43 AM ET

    Allergan fell$. 65 or. 5 percent, to $120.13. Baxter International Inc. rose$. 24 or. 3 percent, to $72.73. Boston Scientific Corp. fell$. 17 or 1.3 percent, to $13.05.

Most Popular Video

Tuesday, 15 Apr 2014 | 4:07 PM ET

"Yahoo's core business is still limping along," says Colin Gillis, BGC Financial, while providing instant reaction to Yahoo's quarterly numbers. "Shark Tank" investor Kevin O'Leary and "The Profit's" Marcus Lemonis weigh in.

Tuesday, 15 Apr 2014 | 11:31 PM ET

John Sculley, former Apple CEO and Managing Partner at Inflexionpoint, discusses his company's acquisitions in Singapore and India.

Tuesday, 15 Apr 2014 | 11:14 PM ET

Will Oswald, Global Head of FICC Research at Standard Chartered, says Beijing has the tools to guide its economy to a soft landing.